The ROE as of September 2024 (TTM) for Acorda Therapeutics, Inc. (ACOR) is 485.80%

According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 485.80%. This represents a change of 1.47% compared to the average of 30.93% of the last 4 quarters.

Acorda Therapeutics, Inc. (ACOR) Historical ROE (quarterly & annually)

How has ACOR ROE performed in the past?

The mean historical ROE of Acorda Therapeutics, Inc. over the last ten years is -14.64%. The current 485.80% ROE has changed -3417.80% with respect to the historical average. Over the past ten years (40 quarters), ACOR's ROE was at its highest in in the December 2023 quarter at 137.86%. The ROE was at its lowest in in the September 2019 quarter at -93.67%.

Acorda Therapeutics, Inc. (ACOR) ROE by Quarter and Year

Discovering the peaks and valleys of Acorda Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acorda Therapeutics, Inc. (ACOR) Average ROE

How has ACOR ROE performed in the past?

The current ROE of Acorda Therapeutics, Inc. (ACOR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Acorda Therapeutics, Inc. (ACOR) ROE vs. Peers

How is ACOR’s ROE compared to its peers?

Acorda Therapeutics, Inc.’s ROE is greater than Taisho Pharmaceutical Holdings Co., Ltd. (1.04%), less than Shionogi & Co., Ltd. (12.23%), greater than Vivesto AB (-47.38%), less than Pacira BioSciences, Inc. (7.32%), greater than Sunshine Biopharma, Inc. (-16.09%), greater than Lucy Scientific Discovery Inc. (-377.80%), greater than Biofrontera Inc. (-477.13%), greater than Jupiter Wellness, Inc. (-214.35%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-217.58%), less than Lifecore Biomedical, Inc. (26.37%), less than Journey Medical Corporation (5.44%), greater than Akanda Corp. (-543.35%), greater than China Pharma Holdings, Inc. (-60.19%), greater than Universe Pharmaceuticals INC (-14.22%), greater than Sonoma Pharmaceuticals, Inc. (-77.69%), greater than Petros Pharmaceuticals, Inc. (-134.64%), greater than Evoke Pharma, Inc. (-964.02%), greater than Cumberland Pharmaceuticals Inc. (-34.74%), less than Agile Therapeutics, Inc. (104.04%), greater than PainReform Ltd. (-450.64%),

Build a custom stock screener for Acorda Therapeutics, Inc. (ACOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acorda Therapeutics, Inc. (ACOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.